South Africa: First African Country With COVID-19 Vaccine
View pictures in App save up to 80% data.
Shabir Madhi, Professor of Vaccinology at the University of the Witswatersrand to lead the South African OX1COV-19 Vaccine VIDA-Trail.
The very first COVID-19 clinical trials in the entire African continent will begin today, 24 June 2020 in South Africa.
The University of the Witswatersrand made the announcement via a virtual conference they hosted on the 23rd of June 2020.
South Africa currently has 106 000 (+4 518) confirmed cases with more than 2 101 deaths since President Cyril Ramaphosa declared the spread of COVID-19 a state disaster and announced the national lockdown in March.
The University of the Witswatersrand in collaboration with the University of Oxford and the Oxford Jenner Institute, will begin adminstering the OX1COV-19 Vaccine VIDA-Trail in South Africa.
The trail aims to find a working vaccine that will prevent the infection by SARS-CoV-2 which causes cornavirus (COVID-19).
The technical name for the trail vaccine is ChAdOx1 made from the virus ChAdOx1.
If the clinical trials prove successful, it be historical breakthrough not only for South Africa but for the entire world. South Africa has made major efforts to combat the steadily growing virus.
For more information on the OX1COV-19 Vaccine VIDA-Trail in South Africa, visit https://www.eurekalert.org/pub_releases/2020-06/uotw-fcv062320